Exploring the Catalytic Mechanism of Dihydropteroate Synthase: Elucidating the Differences Between the Substrate and Inhibitor (SCOPUS)

Citation

Chotpatiwetchkul W., Boonyarattanakalin K., Gleeson D., & Gleeson, M. Paul. (2017). Exploring the catalytic mechanism of dihydropteroate synthase: Elucidating the differences between the substrate and inhibitor. Organic and Biomolecular Chemistry, 15(26), pp. 5593–5601.

ABSTRACT

Dihydropteroate synthase (DHPS) catalyzes the condensation of 6-hydroxymethyl-7,8-dihydropterin pyrophosphate (DHPPP) with p-aminobenzoic acid (pABA) and is a well validated target for anti-malarial and anti-bacterial drugs. However, in recent years its utility as a therapeutic target has diminished considerably due to multiple mutations. As such, considerable structural biology and medicinal chemistry effort has been expended to understand and overcome this issue. To date no detailed computational analysis of the protein mechanism has been made despite the detailed crystal structures and multiple mechanistic proposals being made. In this study the mechanistic proposals for DHPS have been systematically investigated using a hybrid QM/MM method. We aimed to compare the energetics associated with S_N1 and S_N2 processes, whether the S_N1 process involves a carbocation or neutral DHP intermediate, uncover the identity of the general base in the catalytic mechanism, and understand the differences in substrate vs. inhibitor reactivity. Our results suggest a reaction that follows an S_N1 process with the rate determining step being C–O bond breaking to give a carbocation intermediate. Comparative studies on the inhibitor STZ confirm the experimental observations that it is also a DHPS substrate.

Link to Publication

Exploring the Catalytic Mechanism of Dihydropteroate Synthase: Elucidating the Differences Between the Substrate and Inhibitor

Faculty of Pharmacy, Siam University, Bangkok, Thailand

• Thromboprophylaxis in Multiple Myeloma Patients Receiving Immunomodulatory Drugs
• The Perspective of Stakeholders towards the Problems and Solutions of Health Products Available Through Social Commerce in Thailand
• Prognostic Value of Serum Procalcitonin level for the Diagnosis of Bacterial Infections in Critically-ill Patients
• Formulation and in-vitro evaluation of fast dissolving tablets using superdisintegrant blend with effervescent materia
• Doripenem dosing regimens in Asian critically ill patients with continuous real replacement therapy
• Doripenem dosing in Asian critically ill patients with continuous renal replacement therapy
• Design and characterisation of electrospun shellac-polyvinylpyrrolidone blended micro/nanofibres loaded with monolaurin for application in wound healing